Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients
Crossref DOI link: https://doi.org/10.1186/s13045-016-0369-8
Published Online: 2017-01-04
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Daud, Adil
Gill, Japinder
Kamra, Sheily
Chen, Lei
Ahuja, Amit
